Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 47 (RPL17P47)
- Target
- RPL17P47
- Molecular classification
- Other (Pseudogene, processed pseudogene)
01
Overview
Ribosomal protein L17 pseudogene 47 (RPL17P47) is a processed human pseudogene that corresponds to the ribosomal protein L17 (RPL17) gene[5][8][10]. Pseudogenes are typically nonfunctional sequences that arise from gene duplication or retrotransposition events, and they do not encode functional proteins. RPL17P47 is not expressed as a protein and has no described biological or therapeutic relevance; it is not considered a drug target, receptor, or enzyme. While some pseudogenes can have regulatory functions (such as acting as competing endogenous RNAs), there are no data indicating RPL17P47 has such a role[8]. Its presence is primarily of interest for genome annotation and evolutionary studies.
- Other names
- RPL17_17_1624RPL17P47
02
Biological functions
Other (No known biological function; does not encode a functional protein[10])
03
Disease associations
Other (No direct role in disease as a functional gene; pseudogenes may have regulatory roles in rare contexts, but no evidence for this in RPL17P47[8][10])
Beyond the preview
Go deeper on Ribosomal protein L17 pseudogene 47 (RPL17P47).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 47 (RPL17P47).